Loading...

FITC anti-mouse CD45 Antibody

Pricing & Availability
Clone
30-F11 (See other available formats)
Regulatory Status
RUO
Other Names
T200, Ly-5, LCA
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
30-f11
C57BL/6 splenocytes stained with 30-F11 FITC
  • 30-f11
    C57BL/6 splenocytes stained with 30-F11 FITC
Compare all formats See FITC spectral data
Cat # Size Price Quantity Check Availability Save
103107 50 µg $36
Check Availability


Need larger quantities of this item?
Request Bulk Quote
103108 500 µg $105
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD45 is a 180-240 kD glycoprotein also known as the leukocyte common antigen (LCA), T200, or Ly-5. It is a member of the protein tyrosine phosphatase (PTP) family, expressed on all hematopoietic cells except mature erythrocytes and platelets. There are different isoforms of CD45 that arise from variable splicing of exons 4, 5, and 6, which encode A, B, and C determinants, respectively. CD45 plays a key role in TCR and BCR signal transduction. These isoforms are very specific to the activation and maturation state of the cell as well as cell type. The primary ligands for CD45 are galectin-1, CD2, CD3, CD4, TCR, CD22, and Thy-1.

Product Details
Technical data sheet

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse thymus or spleen
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with FITC under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Application Notes

Clone 30-F11 reacts with all isoforms and both CD45.1 and CD45.2 alloantigens of CD45.

Additional reported applications (for relevant formats) include: immunoprecipitation3, complement-dependent cytotoxicity1,5, immunohistochemistry (acetone-fixed frozen sections, zinc-fixed paraffin-embedded sections and formalin-fixed paraffin-embedded sections)4,6, Western blotting7, and spatial biology (IBEX)10,11. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 103163 and 103164).

Application References

(PubMed link indicates BioLegend citation)
  1. Podd BS, et al. 2006. J. Immunol. 176:6532. (FC, CMCD) PubMed
  2. Haynes NM, et al. 2007. J. Immunol. 179:5099. (FC)
  3. Ledbetter JA, et al. 1979. Immunol. Rev. 47:63. (IP)
  4. Simon DI, et al. 2000. J. Clin. Invest. 105:293. (IHC)
  5. Seaman WE. 1983. J. Immunol. 130:1713. (CMCD)
  6. Cornet A, et al. 2001. P. Natl. Acad. Sci. USA 98:13306. (IHC)
  7. Tsuboi S and Fukuda M. 1998. J. Biol. Chem. 273:30680. (WB) PubMed
  8. Liu F, et al. 2012. Blood. 119:3295. PubMed
  9. Pelletier AN, et al. 2012. J. Immunol. 188:5561. PubMed
  10. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  11. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Johnson DC, et al. 2018. Nat Med. 24:1151. PubMed
  2. Yu X, et al. 2020. Nat Commun. 11:1110. PubMed
  3. Xu X, et al. 2020. Chin Med. 15:33. PubMed
  4. Shakya S, et al. 2020. MethodsX. 7:101027. PubMed
  5. Garo LP, et al. 2021. Nat Commun. 12:2419. PubMed
  6. Hutton C, et al. 2021. Cancer Cell. 39:1227. PubMed
  7. Nederlof R, et al. 2022. Front Immunol. 13:908023. PubMed
  8. Kataru RP, et al. 2021. Sci Signal. 14:. PubMed
  9. Li Z, et al. 2022. Nat Commun. 13:1845. PubMed
  10. J Gautam, X Zhang, Y Yao 2016. Sci Rep. 6:36450. PubMed
  11. Li Y, et al. 2020. Nat Commun. 2.350694444. PubMed
  12. Gabitova-Cornell L, et al. 2020. Cancer Cell. 38(4):567-583.e11. PubMed
  13. Huang Z et al. 2017. Cell metabolism. 26(3):493-508 . PubMed
  14. McGill BE et al. 2018. The Journal of Neuroscience. 38(1):200-219 . PubMed
  15. Hofmann I, et al. 2022. J Pharmacol Exp Ther. Online ahead of print. PubMed
  16. Hulsebus HJ, et al. 2022. Front Immunol. 13:884719. PubMed
  17. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  18. El-Hindi K, et al. 2022. Int J Mol Sci. 23:. PubMed
  19. Qi Z, et al. 2022. Nat Commun. 13:182. PubMed
  20. Ma J, et al. 2020. Adv Sci (Weinh). 7:2000609. PubMed
  21. Sharma GP, et al. 2021. PLoS One. 16:e0259042. PubMed
  22. Zhu H, et al. 2018. Elife. 7:. PubMed
  23. Rodriguez-García A, et al. 2021. Nat Commun. 12:877. PubMed
  24. Tcheng M, et al. 2021. Blood. 137:3518. PubMed
  25. Prado C, et al. 2021. J Neuroinflammation. 18:292. PubMed
  26. Wang M, et al. 2022. Theranostics. 12:4513. PubMed
  27. Adachi Y, et al. 2022. Nat Commun. 13:5117. PubMed
  28. Bauer KM, et al. 2022. JCI Insight. 7:. PubMed
  29. Sepe JJ, et al. 2022. JACC Basic Transl Sci. 7:915. PubMed
  30. Abdala-Valencia H, et al. 2014. Am J Physiol Lung Cell Mol Physiol. 307:482. PubMed
  31. Shao Y, et al. 2019. Diabetes. 68:2131. PubMed
  32. Lee AK, et al. 2020. Radiat Res. 193:305. PubMed
  33. Choi H et al. 2019. Cell Rep. 27(3):806-819 . PubMed
  34. Agelidis A, et al. 2019. Front Immunol. 10:500. PubMed
  35. Neumann AM et al. 2017. PloS one. 12(11):e0187330 . PubMed
  36. Pan D, et al. 2022. Cancer Res. 82:2748. PubMed
  37. Rao E, et al. 2021. Sci Immunol. 6:. PubMed
  38. Saito S, et al. 2020. Nutrients. 12:. PubMed
  39. Liu X, et al. 2020. Nature. . PubMed
  40. Liang W, et al. 2020. Nat Commun. 4.563888889. PubMed
  41. Zhang Q, et al. 2019. PLoS Biol. 17:e3000330. PubMed
  42. Tsuchiya N, et al. 2020. Cell Reports. 29(1):162-175.e9.. PubMed
  43. Ohigashi I, et al. 2020. Cell Reports. 29(9):2901-2916.e6.. PubMed
  44. Ihara S, et al. 2022. PLoS Negl Trop Dis. 16:e0010323. PubMed
  45. Talma N, et al. 2021. Aging Cell. 20:e13450. PubMed
  46. Zhao G, et al. 2020. Sci Adv. 6:00. PubMed
  47. Evren E, et al. 2020. Immunity. 54(2):259-275.e7. PubMed
  48. Wosczyna MN, et al. 2021. Cell Stem Cell. 28(7):1323-1334.e8. PubMed
  49. Pan H, et al. 2020. Mol Psychiatry. . PubMed
  50. Wang X, et al. 2021. Front Cell Dev Biol. 632805:9. PubMed
  51. Zhang C, et al. 2020. Cell Metabolism. 31(1):148-161.e5.. PubMed
  52. Lu Y, et al. 2020. Cell. 180(6):1081-1097. PubMed
  53. Meixiong J et al. 2019. Immunity. 50(5):1163-1171 . PubMed
  54. Xiao X, et al. 2019. Cell Discov. 5:2. PubMed
  55. Dai B, et al. 2022. Theranostics. 12:7603. PubMed
  56. Francian A, et al. 2021. J Drug Target. 29:754. PubMed
  57. Johansen AZ, et al. 2022. Pharmaceutics. 14:. PubMed
  58. Rolfes S, et al. 2020. Neurobiol Dis. 144:105024. PubMed
  59. Zhang Z, et al. 2021. Oncoimmunology. 10:1912472. PubMed
  60. Han C, et al. 2021. Cell Reports. 34(6):108706. PubMed
  61. Emgård J, et al. 2018. Immunity. 143:419. PubMed
  62. Parada-Kusz M, et al. 2018. Dis Model Mech. 11:. PubMed
  63. Feng Y, et al. 2018. Kidney Dis (Basel). 4:95. PubMed
  64. Wosczyna MN et al. 2019. Cell Rep. 27(7):2029-2035 . PubMed
  65. Plein A, et al. 2018. Nature. 562:223. PubMed
  66. Kobayashi S, et al. 2019. J Immunol. 203:1447. PubMed
  67. Green DP, et al. 2019. Neuron. 101:412. PubMed
  68. Davidson S, et al. 2020. Cell Reports. 31(7):107628. PubMed
  69. Zhang W, et al. 2021. Cell Prolif. 54:e13058. PubMed
  70. Gui J, et al. 2020. Nat Cancer. 1:603. PubMed
  71. Hore ZL, et al. 2021. Wellcome Open Res. 6:68. PubMed
  72. Dane EL, et al. 2022. Nat Mater. 21:710. PubMed
  73. Yao L, et al. 2021. J Bone Miner Res. 36:1159. PubMed
  74. Koujah L, et al. 2021. Ocul Surf. 21:238. PubMed
  75. Kumari A, et al. 2022. Sci Rep. 12:15273. PubMed
  76. Li P, et al. 2021. Nat Immunol. 22:1107. PubMed
  77. Zhang X, et al. 2022. Cells. 11:. PubMed
  78. Kucinski I, et al. 2020. EMBO J. :e104983. PubMed
  79. Müller A, et al. 2020. J Clin Invest. 5765:130. PubMed
  80. Liang Z, et al. 2020. Pain. 161:2089. PubMed
  81. Deng Z, et al. 2017. Oncogene. 36:639. PubMed
  82. Barman PK, et al. 2019. J Immunol. 202:2720. PubMed
  83. Lim D, et al. 2018. Front Physiol. 9:47. PubMed
  84. Zein HS, et al. 2022. Sci Rep. 12:4834. PubMed
  85. Luo W, et al. 2022. Front Immunol. 13:816761. PubMed
  86. Kusuyama J, et al. 2021. Cell Metabolism. 33(5):939-956.e8. PubMed
  87. Srivastava S, et al. 2019. Cancer Cell. 35:489. PubMed
  88. Wang ECE, et al. 2019. Cell Stem Cell. 24:654. PubMed
  89. Cervera–Carrascon V, et al. 2020. Oncoimmunology. 9:1761229. PubMed
  90. Morimoto A, et al. 2021. Nat Commun. 12:2136. PubMed
  91. Poillet-Perez L, et al. 2020. Nat Cancer. 1:923. PubMed
  92. Du Y, et al. 2022. Nat Commun. 13:231. PubMed
  93. Gañán-Gómez I, et al. 2022. Nat Med. . PubMed
  94. Chin AL, et al. 2021. Nat Commun. 12:5138. PubMed
  95. Zhang K, et al. 2014. PLoS Pathog. 10:1004385. PubMed
  96. Mencarelli A, et al. 2016. Sci Rep. 6:30802. PubMed
  97. Lu X, et al. 2016. Nat Commun. 7: 12719. PubMed
  98. Hu J, et al. 2020. Theranostics. 7.154166667. PubMed
  99. Li J, et al. 2020. Elife. 9:00. PubMed
  100. Rosa JM, et al. 2021. British Journal of Pharmacology. . PubMed
  101. Derecka M, et al. 2020. Nat Immunol. 261:21. PubMed
  102. Wan X, et al. 2018. Nature. 560:107. PubMed
  103. Al–Zaher AA, et al. 2018. Mol Ther Oncolytics. 0.376388889. PubMed
  104. Hepler C et al. 2018. eLife. 7 pii: e39636. PubMed
  105. Goldfarb Y, et al. 2021. J Exp Med. 218:. PubMed
  106. Zeng Q, et al. 2022. Front Immunol. 13:740805. PubMed
  107. Ye P, et al. 2022. Front Cardiovasc Med. 8:810477. PubMed
  108. Brigas HC, et al. 2021. Cell Reports. 36(9):109574. PubMed
  109. Zhu H, et al. 2021. Cell Metabolism. :. PubMed
  110. Nguyen PT, et al. 2020. Cell. 182(2):388-403.e15. PubMed
  111. Liu CY, et al. 2020. Cell Rep. 33:108275. PubMed
  112. Cai Y, et al. 2019. Cell Rep. 27:3034. PubMed
  113. Crowell PD et al. 2019. Cell Rep. 28(6):1499-1510 . PubMed
  114. Maetzig T, et al. 2017. Mol Ther. 25:606. PubMed
  115. Burr ML, et al. 2019. Cancer Cell. 36:385. PubMed
  116. Wang F, et al. 2019. MAbs. 12:1685350. PubMed
  117. Ji DX, et al. 2019. Nat Microbiol. 1.644444444. PubMed
  118. Liu S, et al. 2020. Cell Host & Microbe. 26(6):779-794.e8.. PubMed
  119. Liang J, et al. 2020. Sci Adv. 6:eabc3646. PubMed
  120. Ruan C, et al. 2020. Brain Behav Immun. 83:180. PubMed
  121. Sefik E, et al. 2021. Nat Biotechnol. . PubMed
  122. Watanabe Y, et al. 2020. J Biol Chem. 295:17632. PubMed
  123. Engler AE, et al. 2020. Cell Reports. 33(13):108553. PubMed
  124. Coronel MM, et al. 2020. Sci Adv. 6:eaba5573. PubMed
  125. Pundir P, et al. 2020. Cell Host & Microbe. 26(1):114-122. PubMed
  126. Gastelum‐Aviña P et al. 2016. Journal of immunological methods. 438:42-50 . PubMed
  127. Zhou J, et al. 2019. Nat Commun. 10:2427. PubMed
  128. Yu X, et al. 2019. Nat Commun. 10:574. PubMed
  129. Su S et al. 2018. Cell. 175(2):442-457 . PubMed
  130. Milner MT, et al. 2022. STAR Protoc. 3:101295. PubMed
  131. Zhang X, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  132. Xiao L, et al. 2021. Clin Cancer Res. 27:4338. PubMed
  133. Kotas ME, et al. 2022. JCI Insight. :. PubMed
  134. Rashid MH, et al. 2021. Oncol Rep. 45:1171. PubMed
  135. Jiang Y, et al. 2021. Cell Death Differ. 28:3009. PubMed
  136. Agelidis A, et al. 2021. JCI Insight. 6: . PubMed
  137. Monaghan KL, et al. 2020. J Vis Exp. . PubMed
  138. Yamakawa D, et al. 2021. Cell Reports. 34(10):108817. PubMed
  139. Galle-Treger L, et al. 2016. Nat Commun. 7:13202. PubMed
  140. Wang Z et al. 2018. Immunity. 49(1):80-92 . PubMed
  141. Sarvi S et al. 2018. Cell chemical biology. 25(12):1456-1469 . PubMed
  142. Hu Y, et al. 2021. Cell Death Dis. 12:743. PubMed
  143. Minhas PS, et al. 2021. Nature. 590:122. PubMed
  144. Zhang X, et al. 2021. Mol Cancer Res. 19:1076. PubMed
  145. Liu S, et al. 2022. J Neuroinflammation. 19:35. PubMed
  146. Xiao Y, et al. 2022. Nat Commun. 13:758. PubMed
  147. Ali S, et al. 2021. PLoS One. 16:e0246646. PubMed
  148. Yang Z, et al. 2021. Nat Commun. 12:4852. PubMed
  149. Long JT, et al. 2022. Elife. 11:. PubMed
  150. Bravo-Caparrós I, et al. 2020. FASEB J. 34:5951. PubMed
  151. Zhang P, et al. 2022. Nat Commun. 13:1588. PubMed
  152. Sirvinskas D, et al. 2022. iScience. 25:104202. PubMed
  153. Ito K, et al. 2014. Proc Natl Acad Sci U S A. 111:3080. PubMed
  154. Saunders L, et al. 2015. Sci Transl Med. 7: 302ra136. PubMed
  155. Jiang Q, et al. 2020. JCI Insight. 5:00. PubMed
  156. Hasegawa T, et al. 2020. Sci Rep. 10:13480. PubMed
  157. Johnson DC, et al. 2020. Cell Death Dis. 0.894444444. PubMed
  158. Li CM, et al. 2020. Cell Reports. 33(13):108566. PubMed
  159. Zhang L, et al. 2021. iScience. 24(9):102942. PubMed
  160. Qi F, et al. 2019. Front Microbiol. 2.140277778. PubMed
  161. Yu JM, et al. 2019. Nat Commun. 4.388888889. PubMed
  162. Li Z, et al. 2022. Nat Commun. 13:6321. PubMed
  163. Hou Y, et al. 2021. Sci Transl Med. 13:. PubMed
  164. Xu G, et al. 2022. Front Pharmacol. 13:896601. PubMed
  165. Zhou J, et al. 2022. Int J Oncol. 61: . PubMed
  166. Wang W, et al. 2021. J Am Heart Assoc. 10:e019142. PubMed
  167. Song J, et al. 2021. Am J Physiol Heart Circ Physiol. 320:H323. PubMed
  168. Zeis P, et al. 2020. Immunity. 53:775. PubMed
  169. Ben-Yehuda H, et al. 2021. Mol Neurodegener. 16:39. PubMed
  170. Kim H, et al. 2020. Biomed Rep. 0.589583333. PubMed
  171. Ovadya Y, et al. 2018. Nat Commun. 9:5435. PubMed
  172. Zheng B, et al. 2021. Bioact Mater. 6:3879. PubMed
  173. Ferrer-Font L, et al. 2020. Elife. 9:. PubMed
  174. Sakai H, et al. 2022. iScience. 25:103928. PubMed
  175. Walker MT, et al. 2021. Front. Allergy. 2:. PubMed
  176. Kataru RP, et al. 2022. Front Aging. 3:864860. PubMed
  177. Pan Y, et al. 2021. Br J Pharmacol. 178:4907. PubMed
  178. Tomimatsu M, et al. 2022. Sci Rep. 12:16656. PubMed
  179. Chen M, et al. 2019. Cell Stem Cell. 25:501. PubMed
  180. Sema Kurtulus et al. 2018. Immunity. 50(1):181-194 . PubMed
  181. Liu L et al. 2018. Cell stem cell. 23(4):544-556 . PubMed
  182. Zhao N, et al. 2018. J Clin Invest. 26:84. PubMed
  183. Hameed H, et al. 2022. Int J Mol Sci. 23:. PubMed
  184. Ding R, et al. 2022. J Neuroinflammation. 19:137. PubMed
  185. Liu R, et al. 2020. Eur J Vasc Endovasc Surg. 60:254. PubMed
  186. Fan ZP, et al. 2021. Front Immunol. 12:743354. PubMed
  187. Okada R, et al. 2021. EBioMedicine. 67:103345. PubMed
  188. Ding L et al. 2018. Cell reports. 25(11):2972-2980 . PubMed
  189. Hao T, et al. 2019. Nat Commun. 10:3665. PubMed
  190. Zegarra‐Ruiz DF et al. 2018. Cell host & microbe. 25(1):113-127 . PubMed
  191. Chao Y, et al. 2020. Sci Adv. 6:eaaz4204. PubMed
  192. Kataru RP, et al. 2019. Cancer Immunol Res. 7:1345. PubMed
  193. Krivtsov AV, et al. 2020. Cancer Cell. 36(6):660-673.e11.. PubMed
  194. Hu X, et al. 2020. Neoplasia. 1.290972222. PubMed
  195. Chen L, et al. 2021. Theranostics. 11:6668. PubMed
  196. Sugita Y, et al. 2021. Oncol Rep. 45:. PubMed
  197. Banskota S, et al. 2021. Inflamm Bowel Dis. 27:914. PubMed
  198. Ruan Y, et al. 2022. Exp Ther Med. 23:47. PubMed
  199. Wang R, et al. 2022. J Immunother Cancer. 10:. PubMed
  200. Liao X, et al. 2022. JCI Insight. 7:. PubMed
  201. Kelley WJ, et al. 2022. JCI Insight. 7: . PubMed
  202. Cerina M, et al. 2017. Brain Behav Immun. 59:103-117. PubMed
  203. Simoes Eugénio M, et al. 2020. Cancers (Basel). 12:00. PubMed
  204. Tr änkner D, et al. 2019. Cell Rep. 29:791. PubMed
  205. Lee C, et al. 2020. Front Immunol. 11:77. PubMed
  206. Eckert EC, et al. 2020. Mol Ther Oncolytics. 0.710416667. PubMed
  207. Poillet–Perez L, et al. 2018. Nature. 563:569. PubMed
  208. Padhye A, et al. 2019. Sci Rep. 9:4819. PubMed
  209. Zhou Y, et al. 2022. Theranostics. 12:5488. PubMed
  210. Sheng D, et al. 2022. J Immunother Cancer. 10:. PubMed
  211. El-Obeid A, et al. 2021. Exp Ther Med. 22:1081. PubMed
  212. Sharma R, et al. 2021. J Neuroinflammation. 72:18. PubMed
  213. Watanabe Y, et al. 2020. J Biol Chem. . PubMed
  214. Sheng J, et al. 2021. eLife. 10:00. PubMed
  215. Le TM et al. 2018. Journal of neurochemistry. 145(2):139-153 . PubMed
  216. Lee EKS, et al. 2018. Cell Host Microbe. 23:121. PubMed
  217. Shao Y, et al. 2019. Stem Cells. 37:1331. PubMed
  218. Krotova K, et al. 2019. Mol Ther Oncolytics. 15:166. PubMed
  219. Gupta R, et al. 2020. Cell Stem Cell. 26:527. PubMed
  220. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  221. Li M, et al. 2020. Nat Commun. 4051:11. PubMed
  222. Ma Y, et al. 2020. Front Immunol. 11:586685. PubMed
  223. Pessoa Rodrigues C, et al. 2020. Sci Adv. 6:eaaz4815. PubMed
  224. Guarnerio J, et al. 2018. Nat Commun. 9:66. PubMed
  225. Wolf Y, et al. 2019. Cell. 179:219. PubMed
  226. Li CY, et al. 2022. Int J Mol Sci. 23:. PubMed
  227. Wang H, et al. 2022. J Cancer. 13:2126. PubMed
  228. Zhang SJ, et al. 2021. Adv Sci (Weinh). 8:2003410. PubMed
  229. Zhang L, et al. 2021. Mol Ther. 29:744. PubMed
  230. Andreata F, et al. 2021. STAR Protoc. 2:100831. PubMed
  231. Ichinose M, et al. 2021. Sci Rep. 7200:11. PubMed
  232. Zhang B, et al. 2021. Front Neurol. 607370:12. PubMed
  233. Dingler FA, et al. 2020. Mol Cell. . PubMed
  234. Wan Y, et al. 2020. Cell Rep. 33:108346. PubMed
  235. Badgujar DC, et al. 2020. PLoS Pathog. 16:e1009016. PubMed
RRID
AB_312972 (BioLegend Cat. No. 103107)
AB_312973 (BioLegend Cat. No. 103108)

Antigen Details

Structure
Protein tyrosine phosphatase (PTP) family, 180-240 kD
Distribution

All hematopoietic cells except mature erythrocytes and platelets

Function
Phosphatase, T and B cell activation
Ligand/Receptor
Galectin-1, CD2, CD3, CD4, TCR, CD22, Thy-1
Cell Type
B cells, Dendritic cells, Mesenchymal Stem Cells, Tregs
Biology Area
Cell Biology, Immunology, Inhibitory Molecules, Innate Immunity, Neuroscience, Neuroscience Cell Markers, Stem Cells
Molecular Family
CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Trowbridge IS, et al. 1993. Annu. Rev. Immunol. 12:85.
3. Kishihara K, et al. 1993. Cell 74:143.
4. Pulido R, et al. 1988. J. Immunol. 140:3851.

Gene ID
19264 View all products for this Gene ID
UniProt
View information about CD45 on UniProt.org

Other Formats

View All CD45 Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse CD45 30-F11 FC
Biotin anti-mouse CD45 30-F11 FC
FITC anti-mouse CD45 30-F11 FC
PE anti-mouse CD45 30-F11 FC
PE/Cyanine5 anti-mouse CD45 30-F11 FC
Purified anti-mouse CD45 30-F11 FC,IHC-F,CyTOF®,IP,CMCD,IHC,WB
PE/Cyanine7 anti-mouse CD45 30-F11 FC
APC/Cyanine7 anti-mouse CD45 30-F11 FC
Alexa Fluor® 488 anti-mouse CD45 30-F11 FC,SB
Alexa Fluor® 647 anti-mouse CD45 30-F11 FC,ICC,IHC,3D IHC,SB
Pacific Blue™ anti-mouse CD45 30-F11 FC
Alexa Fluor® 700 anti-mouse CD45 30-F11 FC,SB
PerCP/Cyanine5.5 anti-mouse CD45 30-F11 FC
PerCP anti-mouse CD45 30-F11 FC
Alexa Fluor® 594 anti-mouse CD45 30-F11 IHC-F,FC,3D IHC
Brilliant Violet 421™ anti-mouse CD45 30-F11 FC,SB
Brilliant Violet 570™ anti-mouse CD45 30-F11 FC
Brilliant Violet 510™ anti-mouse CD45 30-F11 FC
Brilliant Violet 605™ anti-mouse CD45 30-F11 FC
Purified anti-mouse CD45 (Maxpar® Ready) 30-F11 FC,CyTOF®
PE/Dazzle™ 594 anti-mouse CD45 30-F11 FC
Brilliant Violet 711™ anti-mouse CD45 30-F11 FC
Brilliant Violet 785™ anti-mouse CD45 30-F11 FC
Brilliant Violet 650™ anti-mouse CD45 30-F11 FC
APC/Fire™ 750 anti-mouse CD45 30-F11 FC
Brilliant Violet 750™ anti-mouse CD45 30-F11 FC
TotalSeq™-A0096 anti-mouse CD45 30-F11 PG
TotalSeq™-B0096 anti-mouse CD45 30-F11 PG
Ultra-LEAF™ Purified anti-mouse CD45 30-F11 FC,CyTOF®,IP,CMCD,IHC,WB
Spark Blue™ 550 anti-mouse CD45 30-F11 FC
Spark NIR™ 685 anti-mouse CD45 30-F11 FC
TotalSeq™-C0096 anti-mouse CD45 30-F11 PG
Spark YG™ 570 anti-mouse CD45 30-F11 IHC-F
PE/Fire™ 640 anti-mouse CD45 30-F11 FC
APC/Fire™ 810 anti-mouse CD45 30-F11 FC
PE/Fire™ 700 anti-mouse CD45 30-F11 FC
Spark Violet™ 538 anti-mouse CD45 30-F11 FC
Spark YG™ 593 anti-mouse CD45 30-F11 FC
Spark Blue™ 574 anti-mouse CD45 Antibody 30-F11 FC
Spark UV™ 387 anti-mouse CD45 30-F11 FC
PE/Fire™ 810 anti-mouse CD45 30-F11 FC
Spark Red™ 718 anti-mouse CD45 (Flexi-Fluor™) 30-F11 FC
Spark PLUS UV™ 395 anti-mouse CD45 30-F11 FC
Go To Top Version: 2    Revision Date: 05/14/2013

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login/Register
Remember me
Forgot your password? Reset Password
Request an Account